Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in Rats.
Japjec M, Horvat Pavlov K, Petrovic A et al. · Biomedicines · PMID 34829776
Study summary
Main finding
Treated animals showed smaller defects, improved functional and mechanical measures, and less muscle atrophy. Histology and inflammatory and oxidative-stress markers were assessed through 42 days.
Rats after surgical quadriceps muscle–tendon separation
How the study was set up
Researchers separated the quadriceps tendon from muscle in rats and assessed repair at several points through 42 days.
What the researchers measured
Function, mechanical strength, defect size, muscle atrophy, microscopic healing, and nitric-oxide and oxidative-stress markers were measured.
How to read this evidence
Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.
Results in context
The findings concern a deliberately created tendon-muscle separation. Changes in signaling markers accompany repair but do not by themselves establish which pathway caused it.
What this does not establish
A deliberately separated rat muscle–tendon junction is not a human sports injury. These results do not establish clinical recovery or safety.
Publication & source
Why this paper is included
The compound is a named subject of the publication title.
Publication indexing
Journal Article
Source checked
October 4, 2026. Years follow journal issues; online-first dates may differ.